Science. Supply Chain. Certainty.
Cryoportal Login Request a Quote Menu

INTEGRATED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES INDUSTRY

652
 Active Clinical Trials
10
 Commercial Products
650,000+
 Shipments
150+
 Countries
Box-for-Q12023 
2022’s Data ManagementTransitionsWebinar

2022’s Data Management Transitions Webinar

Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?

  • How will capacity and connectivity challenges impact carrier services and packaging technology providers?
  • How can you guarantee the certainty of global coverage and data fidelity for your cell and gene therapy shipments?
WATCH NOW
Download our ISO 21973 White Paper

Download our ISO 21973 White Paper

A leap forward in standardizing the regenerative medicine supply chain

  • Ensuring full compliance at every step in the transportation process
  • Standardization at scale
  • Mitigating risk in a zero failure environment
LEARN MORE

Latest News View All

News Icon
Feb 15, 2022

Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022

News Icon
Feb 9, 2022

Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility

Upcoming Events View All
JUNE15-17

American College of Veterinary Internal Medicine (ACVIM) Forum

Date: June 15-17, 2023
Location: Philadelphia, Pennsylvania

JUN3

Fertility Society of Australia and New Zealand (FSANZ) Annual Conference 2023

Date: June 3-6, 2023
Location: Queensland, Australia

The Latest From Our Blog View All

3 Services Your Biopharmaceutical Supply Chain Partner Should Offer

When it comes to choosing a cell and gene therapy shipping partner, not all providers are created equal. To select the best partner for your organization, it’s important to consider how their solutions will meet your needs for today and in the future.  

Read More

Exclusive Q&A with Bruce McAfee, Director of Bioservices Commercial Support

Cryoport Systems has extended its expertise in temperature-controlled supply chain solutions with vein-to-vein BioServices offerings. BioServices expands our supply chain solutions in order to better serve our expanding clientele and the greater cell and gene industry. 

Read More
Free White Paper
Advanced Therapy Shipper

A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers

Download Now
  • Are you prepared for 2022’s Data Management Transition?
    •

    Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

    Cryoport Systems has officially launched Cryoportal® 2. To view the Cryoportal® 2 training materials, please click here.